Freedom Capital Markets Downgrades Doximity to Hold, Raises Price Target to $27

Benzinga · 1d ago
Freedom Capital Markets analyst Gene Mannheimer downgrades Doximity (NYSE:DOCS) from Buy to Hold and raises the price target from $24 to $27.